Healthcare Services

Induced Pluripotent Stem Cell (iPSC) Market Revenue Expected to Reach $5.74 Billion by 2030 with 9.3% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Induced Pluripotent Stem Cell (iPSC) Market In 2026 And What Value Is Projected For 2030?

The induced pluripotent stem cell (ipsc) market has demonstrated strong growth over recent years. It is anticipated to expand from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to several key factors, including significant breakthroughs in cellular reprogramming research, ethical issues surrounding embryonic stem cells, increased financial support for stem cell investigations, the proliferation of academic research collaborations, and the rising occurrence of chronic and degenerative conditions.

The induced pluripotent stem cell (ipsc) market is anticipated to experience substantial growth over the next few years. This market is projected to reach $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period can be attributed to the broadening of regenerative medicine applications, a surging demand for personalized therapies, increased investment in cell and gene therapy, the growing use of ipscs in neurological and cardiac research, and supportive regulatory environments for advanced therapeutic strategies. Noteworthy trends throughout the projection period involve the expanding utilization of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the development of patient-specific cell lines, a heightened focus on ethical alternatives to embryonic stem cells, and continuous improvements in reprogramming efficiency and cell stability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

What Major Drivers Are Influencing Demand In The Induced Pluripotent Stem Cell (iPSC) Market?

The rising incidence of neurological conditions is anticipated to boost the expansion of the induced pluripotent stem cell market. A neurological disorder describes a medical state impacting the nervous system, encompassing the brain, spinal cord, and nerves. Examples of prevalent neurological disorders include acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present opportunities for investigating disease mechanisms, conducting drug tests, uncovering the roots of neurological disorders, and facilitating the creation of regenerative treatments for ailments such as Parkinson’s and Alzheimer’s disease. As evidence, in October 2023, the World Federation of Neurology (WFN), an international nonprofit neurological organization based in the UK, reported that over 40% of the world’s population was afflicted with a neurological condition, with the total neurological disease burden expected to nearly double by 2050. Consequently, the increasing occurrence of neurological disorders is propelling the induced pluripotent stem cell market’s growth.

What Are The Key Segments Of The Induced Pluripotent Stem Cell (iPSC) Market?

The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

Which Upcoming Trends Are Expected To Influence The Induced Pluripotent Stem Cell (iPSC) Market?

Leading companies in the induced pluripotent stem cell (IPSC) market are engaging in collaborations to advance iPSC technology, aiming to enhance regenerative medicine applications, improve disease modeling, accelerate drug discovery, and develop personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific process and methodologies utilized to reprogram adult somatic cells, such as skin or blood cells, back into a pluripotent state, enabling them to differentiate into any cell type in the body. For example, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, inaugurated joint laboratories dedicated to advancing cellular immunotherapies. This initiative is backed by close to S$30 million, underscoring Singapore’s commitment to fostering biotechnology and healthcare solutions. The collaboration intends to develop scalable manufacturing processes for GMP-grade iPSC products, thereby addressing the challenges involved in translating laboratory innovations into clinically viable therapies.

Who Are The Leading Companies Operating In The Induced Pluripotent Stem Cell (iPSC) Market?

Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Read the full induced pluripotent stem cell (ipsc) market report here:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Induced Pluripotent Stem Cell (iPSC) Market?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Induced Pluripotent Stem Cell (iPSC) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

Noise Mitigation System Global Market Report

https://www.thebusinessresearchcompany.com/report/noise-mitigation-system-global-market-report

Automotive Noise Insulation Parts Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-noise-insulation-parts-global-market-report

Architectural Acoustic Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/architectural-acoustic-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795